Cargando…
Delayed Azithromycin Treatment Improves Recovery After Mouse Spinal Cord Injury
After spinal cord injury (SCI), macrophages infiltrate into the lesion and can adopt a wide spectrum of activation states. However, the pro-inflammatory, pathological macrophage activation state predominates and contributes to progressive neurodegeneration. Azithromycin (AZM), an FDA approved macrol...
Autores principales: | Kopper, Timothy J., McFarlane, Katelyn E., Bailey, William M., Orr, Michael B., Zhang, Bei, Gensel, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851268/ https://www.ncbi.nlm.nih.gov/pubmed/31780896 http://dx.doi.org/10.3389/fncel.2019.00490 |
Ejemplares similares
-
Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury
por: Zhang, Bei, et al.
Publicado: (2015) -
Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment
por: Gensel, John C., et al.
Publicado: (2017) -
Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions
por: Kopper, Timothy J., et al.
Publicado: (2020) -
Mitochondria exert age-divergent effects on recovery from spinal cord injury
por: Stewart, Andrew N., et al.
Publicado: (2021) -
Fighting for recovery on multiple fronts: The past, present, and future of clinical trials for spinal cord injury
por: Dietz, Valerie A., et al.
Publicado: (2022)